Terazosin
Active substance: terazosin
CAPSULE · TERAZOSIN HYDROCHLORIDE 10 mg/1
United StatesActive
Marketing holder: AvKARE
Verified 2026-10-09 · openFDA NDC
- Source: openFDA NDC
- Countries with the substance registered: 1
Composition
- TERAZOSIN HYDROCHLORIDE · 10 mg/1
Import and control
Control by country
- United Statesprescription only
Source: openFDA NDC · record 01a1208c-2736-71bd-9767-1fe98e5f5727,01a1208c-273c-758a-8fed-7733fb23033c,01a1208c-2978-721e-ba7a-c9b260f9f320,01a1208c-4407-794a-b6fc-fa22e8170903,01a1208c-59d1-79e6-9dc7-77fe1b498f47;count=88 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- 42291-823
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- ORAL
Sources
- product · openFDA NDC · 42291-823 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 42291-823 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 42291-823 · Verified 2026-10-09 · open in source